Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Foot ulcers are common among the 30 million Americans suffering from diabetes. They’re the main cause of lower limb amputations, according to the Centers for Disease Control. With diabetes projected to rise to half a billion people worldwide, the need for improved screening and earlier intervention in diabetic foot disease is critical.

That’s why we’re learning about the importance of early intervention, and how an innovative screening device from HyperMed Imaging can potentially help patients stay one step ahead.

HyperMed Imaging, Inc. is the established leader in medical hyperspectral imaging for surface tissue oximetry. Their pioneering technology has been in service since 2006 and has been shown in published clinical research to effectively assess oxyhemoglobin, deoxyhemoglobin, and oxyhemoglobin saturation in superficial tissue for a number of key healthcare applications.

By imaging oxyhemoglobin and deoxyhemoglobin levels, as well as oxygen saturation in superficial tissue, the device provides clinicians a new understanding of perfusion, thereby leading to more informed treatment decisions. Applications include wound care, vascular care, reconstructive surgery, and limb preservation, among others. Stay tuned to learn more.

The Eversense is changing the game for people living with diabetes. This particular device is the first and only long-term CGM that lasts up to 90 days and is placed in your arm.

The Balancing Act returns with an all-new episode covering the latest on Broadway as well as a cutting-edge device improving the lives of those with type 1 diabetes.

On this edition of The Balancing Act, we're diving into fashion, travel, and the importance of taking control of your health. 

Comments

comments